Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-21Clinical Trial Update: Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma [Phase 2]
A Phase 2 trial evaluating relatlimab (anti-LAG-3) plus nivolumab (anti-PD-1) versus lomustine for recurrent glioblastoma has been suspended…
-
CLINICAL_TRIALS withdrawal · 2026-04-14Clinical Trial Update: Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma [Phase 3]
Phase III trial evaluating two brain conformational radiotherapy regimens in combination with chemotherapy for Glioblastoma has been termina…
-
CLINICAL_TRIALS withdrawal · 2026-02-10Clinical Trial Update: HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma [Phase 2]
A Phase 2 trial evaluating HSV G207 with a single radiation dose for children with recurrent high-grade glioma has been withdrawn from Clini…
-
CLINICAL_TRIALS withdrawal · 2025-10-22Clinical Trial Update: Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma [Phase 1]
This clinical trial update indicates the phase I study of activated autologous T cells targeting glioma cancer stem cell antigens in patient…
-
CLINICAL_TRIALS withdrawal · 2025-09-16Clinical Trial Update: SurVaxM Expanded Access Protocol
The expanded access protocol for SurVaxM in glioblastoma is no longer available.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-08-11Clinical Trial Update: Abemaciclib + Pembrolizumab In Glioblastoma [Phase 2]
Clinical trial NCT04118036 studying Abemaciclib plus Pembrolizumab in glioblastoma has been withdrawn (Phase 2).
-
CLINICAL_TRIALS withdrawal · 2025-07-22Clinical Trial Update: A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma [Phase 1]
A Phase 1 clinical trial evaluating bicalutamide with brain re-irradiation for recurrent high-grade glioma/glioblastoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-07-08Clinical Trial Update: Role of Repeat Resection in Recurrent Glioblastoma [NA]
The clinical trial evaluating repeat resection for recurrent glioblastoma has been withdrawn (status: WITHDRAWN).
-
CLINICAL_TRIALS withdrawal · 2025-05-21Clinical Trial Update: Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma [NA]
This clinical trial investigating cerebrospinal fluid genetic testing to diagnose and monitor glioblastoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-04-10Clinical Trial Update: Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy [Phase 4]
A Phase 4 trial evaluating post-operative adjuvant therapy with or without GammaTile plus systemic therapy for glioblastoma has been withdra…
-
CLINICAL_TRIALS withdrawal · 2024-12-30Clinical Trial Update: Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma [Phase 2]
Phase 2 study evaluating tiragolumab in combination with atezolizumab for recurrent glioblastoma (IDH-wildtype) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-12-04Clinical Trial Update: Lenvatinib, Pembrolizumab, and Tumor Treating Fields (TTFields) for Second-line Treatment of Glioblastoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating lenvatinib, pembrolizumab, and Tumor Treating Fields for second-line glioblastoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-11-20Clinical Trial Update: Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma [Phase 2]
The Phase 2 randomized trial evaluating pembrolizumab with and without Exablate MRgFUS for recurrent glioblastoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma [Phase 1]
A Phase 1 trial investigating dexamethasone and azeliragon for post-resection cerebral edema in glioblastoma patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-09Clinical Trial Update: Treatment of Recurrent GBM With APG-157 Via Expanded Access
Expanded-access trial of APG-157 for recurrent glioblastoma has been discontinued and is no longer available.
-
CLINICAL_TRIALS withdrawal · 2024-07-16Clinical Trial Update: Single Patient Compassionate Use / Expanded Access L-S-Gboxin (Lyophilized Form of S-Gboxin) for the Treatment of Diffuse Midline Glioma
Single-patient compassionate-use/expanded-access study of L-S-Gboxin for diffuse midline glioma is no longer available.
-
CLINICAL_TRIALS withdrawal · 2024-05-06Clinical Trial Update: 89Zr-RO5323441 PET Imaging in Glioblastoma [Phase 2]
A Phase 2 trial evaluating the PET imaging agent 89Zr-RO5323441 for glioblastoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-03-24Clinical Trial Update: Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma [Phase 2, Phase 3]
Clinical trial evaluating Toca 511/Toca FC added to standard therapy for newly diagnosed glioblastoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-20Clinical Trial Update: Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma [NA]
The clinical trial NCT02540135 evaluating fluorescein-guided resection with intraoperative MRI for malignant high-grade gliomas has been wit…
-
CLINICAL_TRIALS withdrawal · 2018-07-19Clinical Trial Update: Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma [Phase 1]
A Phase 1 clinical trial evaluating a nasal spray for recurrent glioblastoma and related gliomas has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: Bevacizumab With or Without Surgery for Adult Glioblastomas [Phase 2]
Phase 2 trial evaluating bevacizumab with or without surgery for adult glioblastomas was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-28Clinical Trial Update: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors [NA]
A clinical trial evaluating 68Ga-DOTATOC PET-CT for brain tumors in children and young adults has been withdrawn from the study.
-
CLINICAL_TRIALS withdrawal · 2017-02-24Clinical Trial Update: Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma [Phase 2]
The Phase 2 trial evaluating G-202 in PSMA-positive glioblastoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-17Clinical Trial Update: More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery [Phase 2]
A Phase 2 trial investigating fluorescence-guided surgery for removing malignant brain tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-03-16Clinical Trial Update: A Phase III Study of Re-Irradiation in Recurrent Glioblastoma [Phase 3]
A Phase III study evaluating re-irradiation for recurrent glioblastoma has been withdrawn.